IL43568A - Cell respiration stimulant compositions containing blood extract and the cardiotonic heptaminol and their productio - Google Patents

Cell respiration stimulant compositions containing blood extract and the cardiotonic heptaminol and their productio

Info

Publication number
IL43568A
IL43568A IL43568A IL4356873A IL43568A IL 43568 A IL43568 A IL 43568A IL 43568 A IL43568 A IL 43568A IL 4356873 A IL4356873 A IL 4356873A IL 43568 A IL43568 A IL 43568A
Authority
IL
Israel
Prior art keywords
blood
extract
blood extract
salt
dry
Prior art date
Application number
IL43568A
Other versions
IL43568A0 (en
Original Assignee
Solco Basel Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solco Basel Ag filed Critical Solco Basel Ag
Publication of IL43568A0 publication Critical patent/IL43568A0/en
Publication of IL43568A publication Critical patent/IL43568A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14Blood; Artificial blood

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Claims (1)

CLAIMS A composition having stimulant effect on cell respiration containing blood extract obtained from blood whic has been carefully freed from diluted and subjected to a dialysis against water or dilute ethanol and then and or a physiologically tolerated acid addition salt A composition according to Claim 1 wherein blood extract having a content of 40 to 45 mg dry substance per ml of extract is A composition according to Claim dosed each dose containing 1 to 5 ml of the blood extract having a content of 40 to 45 mg dry substance pe ml of extract or the equivalent amount of dry o of and 15 to 100 mg of a salt of A composition according to Claim wherein each dose contains 2 ml of the blood extract or the dry thereof and 20 to 80 mg of the heptamlnol A process for the production of a compositio claimed in Claim 1 wherein blood extrac obtained from calf blood which been carefully freed from by ventional then strongly diluted and subjected to a dialysis against water or dilute ethanoli and finally evaporated to a concentration of 40 to 45 mg of dry substance per ml of solution or to a dry lyophilisate or is mixed with or a physiologically accep acid salt thereof in a proportion of to 11 referred to the dry and worked up into injection lyophisates and syrups after adsorption of the active ingredients of the blood extract o substances or into or 14 a A process according to Claim wherein preparations are produced in dosage which per dose 1 to nil of blood extract with a dry content of and 15 to 100 of in the form of its hydrochloride or A process according to Claim 6 wherein dosage having of blood extract 20 to 80 of the heptaniinol salt are A process for the of injectable forms of the composition according to Claims or 7 wherein the salt of is added to the biologically active blood extract in the predetermined and the solution is lyophilised after adjusting the desired concentration by the addition of bidistilled filled into ampoules under sterile A process for the production of solid forms of the composition according to Claims or 7 wherein salt is mixed in the proportion with the biologically active blood extract Ί and the resultant solution is lyophilised or adsorbed solid carriers and or with a lyophilisate or adsorbate of the biologically active blood and the mixture according to or is filled into capsules or mixed with a tablet base material consisting of starch and a swelling or blasting granulated and worked into tablets if given a coating soluble in the after mixing it cacao pressed to form process for the production of liquid forms of composition to Claim or oral wherein A geriatric agent containing 1 to 5 to 225 of blood extract as defined in Claim 1 and 15 to 100 mg of a salt of Compositions according to
1. Claim 1 substantially as herein described exemplified Processes substantially as herein described and exemplified for the production of compositions according to Claim Compositions whenever produced by a process according to any one of Claims 5 to 10 and 16 insufficientOCRQuality
IL43568A 1972-11-16 1973-11-05 Cell respiration stimulant compositions containing blood extract and the cardiotonic heptaminol and their productio IL43568A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1673872 1972-11-16

Publications (2)

Publication Number Publication Date
IL43568A0 IL43568A0 (en) 1974-03-14
IL43568A true IL43568A (en) 1976-05-31

Family

ID=4419791

Family Applications (1)

Application Number Title Priority Date Filing Date
IL43568A IL43568A (en) 1972-11-16 1973-11-05 Cell respiration stimulant compositions containing blood extract and the cardiotonic heptaminol and their productio

Country Status (8)

Country Link
BE (1) BE807455A (en)
DE (1) DE2349186C2 (en)
ES (1) ES420106A1 (en)
FR (1) FR2206941B1 (en)
GB (1) GB1391746A (en)
IL (1) IL43568A (en)
NL (1) NL149371B (en)
SE (1) SE419939B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU206367B (en) * 1988-04-30 1992-10-28 Sandoz Ag Process for producing acid addition salts of steroid carboxylic acid-amidated taurine and glycine, as well as pharmaceutical compositions comprising such salts
DE19518156C2 (en) * 1995-05-17 1997-05-07 Alfons Dr Pfister Use of deproteinized hemodialysate
CA3078625C (en) 2017-10-09 2023-01-17 Terumo Bct Biotechnologies, Llc Lyophilization container and method of using same
WO2020185916A1 (en) 2019-03-14 2020-09-17 Terumo Bct Biotechnologies, Llc Lyophilization container fill fixture, system and method of use

Also Published As

Publication number Publication date
GB1391746A (en) 1975-04-23
FR2206941B1 (en) 1977-09-02
NL7315493A (en) 1974-05-20
BE807455A (en) 1974-03-15
SE419939B (en) 1981-09-07
DE2349186A1 (en) 1974-05-22
NL149371B (en) 1976-05-17
IL43568A0 (en) 1974-03-14
ES420106A1 (en) 1976-03-16
FR2206941A1 (en) 1974-06-14
DE2349186C2 (en) 1982-11-11

Similar Documents

Publication Publication Date Title
CA1040532A (en) Process for producing solid bismuth-containing pharmaceutical compositions
US4775535A (en) Method of preparing controlled long-acting pharmaceutical formulations in unit dosage form having uniform and comparable bioavailability characteristics
IE53537B1 (en) Solid shaped articles
GB1471564A (en) Direct compression tabletting composition and tablets produced therefrom
JPS61115023A (en) Pharmacological medicine containing ibuprofen and manufacture
US3939259A (en) Coating composition and therapeutic preparation incorporating same
JPH0386837A (en) Oral administration of new freeze- dried compound as well as drug, biodrug, nutriment and food
DE4221880A1 (en) Solid and liquid solutions of poorly water-soluble drugs
JPS599539B2 (en) Nitroglycerin aqueous solution and its manufacturing method
JPH04500669A (en) effervescent tablet
CN102258531B (en) Medicinal composition containing adenosine cyclophosphate and meglumine and preparation method thereof
US2656298A (en) Therapeutic product
US4091091A (en) Stabilized nitroglycerin tablets
IL43568A (en) Cell respiration stimulant compositions containing blood extract and the cardiotonic heptaminol and their productio
US2954322A (en) Pharmaceuticals
EP0025686A2 (en) Pharmaceutical composition containing paracetamol, treatment pack comprising said composition and method of reducing liver toxicity effect of paracetamol compositions
US3297529A (en) Magnesium sulfate stabilized choline salicylate
GB630439A (en) Improvements in or relating to pharmaceutical preparations
US3326760A (en) Choline salicylate polygalacturonate therapy
JPS60252415A (en) Stable solid drug composition containing choline salicylate
Ritschel Influence of formulating factors on drug safety of timed-release nitroglycerin tablets
ES387532A1 (en) Procedure to manufacture a medicine. (Machine-translation by Google Translate, not legally binding)
GB1464467A (en) Pharmaceutical composition for the treatment of coronary
CN109125256B (en) Prednisolone injection and preparation method thereof
US2436086A (en) Pectic acid compositions